Damon Runyon identifies today’s most brilliant early career scientists and funds their innovative cancer research.

William Rodney Hardy, PhD
Dr. Hardy is studying a process called oncogene-induced senescence, which stops tumor cell development thus protecting the body against cancer. His goals are to improve our understanding of this process. Dr. Hardy hopes to reveal ways by which oncogene-induced senescence can be exploited as a treatment for cancer.
Project Title: "Elucidation of signal transduction pathways controlling oncogene-induced senescence and their protective roles against melanoma and breast cancer"
Institution: University of Massachusetts Medical School
Sponsor(s) / Mentor(s): Michael R. Green, MD, PhD
Cancer Type: Breast, Skin
Research Area: Senescence



